TG
TDOC icon

TCW Group’s Teladoc Health TDOC Stock Holding History

TCW Group’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.97M Buy
544,697
+97,900
+22% +$549K 0.02% 235
2025
Q4 		$3.13M Hold
446,797
– – 0.02% 232
2025
Q3 		$3.45M Buy
446,797
+6,300
+1% +$49.2K 0.03% 166
2025
Q2 		$3.84M Buy
440,497
+21,800
+5% +$158K 0.03% 202
2025
Q1 		$3.33M Hold
418,697
– – 0.03% 209
2024
Q4 		$3.81M Buy
418,697
+150,317
+56% +$1.45M 0.03% 206
2024
Q3 		$2.46M Buy
+268,380
New +$2.22M 0.02% 241

Other funds holding TDOC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TCW Group's TDOC Position: Q1 2026 in Review

TCW Group increased its Teladoc Health (TDOC) stake by 22% in Q1 2026, buying an estimated $549K and bringing the position to 544,697 shares worth $2.97M. The position accounts for 0.02% of the portfolio, ranked #235.

TCW Group first reported a position in TDOC in Q3 2024 and has held it in 7 quarters since. The position peaked at $3.84M in Q2 2025. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • TCW Group held 544,697 shares of Teladoc Health worth $2.97M as of Q1 2026.
  • TCW Group bought 97,900 Teladoc Health shares in Q1 2026, an estimated $549K.
  • Teladoc Health made up 0.02% of TCW Group's portfolio in Q1 2026, its #235 holding.
  • TCW Group first reported a position in Teladoc Health in Q3 2024 and has held it in 7 quarters since.
  • TCW Group's Teladoc Health position peaked at $3.84M in Q2 2025.
  • 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on TCW Group's 13F filing for Q1 2026, filed 14 May 2026.